Barcelona

• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• DB-1311 in Combination with BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors Pending
  2025-523895-22-00 4 Non-small cell lung cancer (NSCLC)
• A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 Pending
  2025-523911-13-00 5 Narcolepsy Type 1
• Clinical trial to evaluate the clinical and microbiological impact of methenamine hippurate as an alternative prophylaxis in recurrent urin … Pending
  2025-523922-42-00 6 recurrent urine infections
• A study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate r … Pending
  2025-524005-32-00 4 Rheumatoid arthritis
• A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma (SOLAIRIA-1) Pending
  2025-524040-35-00 5 Severe uncontrolled asthma
• ​​AMG 436 as monotherapy and combination therapy in participants with Microsatellite Instability-High/Mismatch Repair Deficient Solid Tumors … Pending
  2025-524056-63-00 1 microsatellite instability high/mismatch repair deficient (MSI-H/dMMR)
• A clinical trial to provide continued access to remibrutinib (LOU064) for people who are benefiting from it in a previous remibrutinib trial Pending
  2025-524078-40-00 5 Chronic Spontaneous Urticaria
• Phase II/III randomized controlled open-label trial to evaluate the efficacy and safety of personalized tissue engineered veins in patients … Pending
  2025-524103-69-00 10 Chronic Venous Insufficiency
• First time in human (FTIH) study to investigate the safety and preliminary activity of GSK5533524 alone or in combination in adult participa … Pending
  2025-524165-25-00 1 Neoplasms
• A study of cemsidomide and dexamethasone in subjects with relapsed or refractory multiple myeloma (r/r MM) Pending
  2025-524181-26-00 4 relapsed/refractory multiple myeloma
• Mechanisms of Resistance to anti-PD-1 Therapy in cutaneous Squamous Cell Carcinomas: Impact of Tumor Cell Plasticity on Promoting Myeloid Su … Pending
  2025-524255-32-00 4 Cutaneous squamous cell carcinoma (ccSCC)
• Phase IV, randomized, open label, parallel groups clinical trial for evaluating the early Stop of antibiotic Treatment in high-risk febrile … Pending
  2025-524264-38-00 6 Infectious diseases
• BETRI-Prospective: Asthma control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 µg]) vs Single Inhaler ICS/LABA (200/ … Pending
  2025-524289-56-00 6 Asthma
• A medical research to evaluate if MaaT013 is safe and helps children and adolescent with GI-aGvHD after failed two prior therapies. Pending
  2025-524302-15-00 4 Gastrointestinal Acute Graft-versus-Host Disease (GI-aGvHD)
• Phase III randomized international open label clinical trial of treatment Intensification with docetaxel plus apalutamide in patients with m … Pending
  2025-524408-30-01 5 Metastatic hormone-sensitive prostate cancer
• A study of SGX-001 in patients with chronic granulomatous disease caused by p47phox deficiency (p47-CGD) Pending
  2025-524423-50-00 7 Chronic granulomatous disease (CGD) caused by p47phox deficiency (p47-
• PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR … Pending
  2025-524613-89-00 9 HER2 positive advanced breast cancer
• Trial to study the safety and pharmacokinetics of ODM-212 combined with existing cancer treatments Pending
  2025-524620-22-00 9 Neoplasms benign malignant and unspecified (incl. cysts and polyps)
• Application of radiomics for diagnosis and follow-up of cardiovascular device infections: PREDICT study Pending
  2025-524624-21-00 6 Cardiovascular device infections
• CD5CAR-NK cells for refractory invasive mold disease Pending
  2025-524638-24-00 1 refractory invasive mold disease
• Optimizing Aspirin Use for Preeclampsia Prevention Pending
  2025-524646-94-00 11 Obstetrics – Preeclampsia
• Immunosuppressant Discontinuation in Elderly patients with ulcerative colitis And long-term remission Pending
  2025-524675-23-00 6 Ulcerative Colitis
• Phase IV study to evaluate the safety and efficacy of maribavir in reducing Epstein–Barr virus in young adult kidney transplant recipients. Pending
  2025-524786-25-00 6 Transplant patients with high recurrent Epstein-Barr infection

Showing 241–264 of 3,391 trials